Cannabis Market worth $90.4 billion by 2026

2.4 min readPublished On: June 21st, 2022By

Chicago – According to MarketsandMarkets™, the global cannabis market size was estimated to be valued at USD 20.5 billion in 2020. It is projected to reach USD 90.4 billion by 2026, recording a CAGR of 28.0%, in terms of value. Various product developments happening in the category, in tandem with novel product delivery solutions to create opportunities within the cannabis market.

The concentrates segment projected to grow at highest CAGR in the cannabis market

The concentrates segment within the cannabis market, by product type, is estimated to be growing at the fastest rate from 2020-2026. This is majorly due to the varied number of forms in which concentrates let one experience cannabis in a multitude of ways, such as shatter, rosin, wax, crumble, oil, dabs, and tinctures. Concentrates also offer a wide variety of delivery methods, such as smoking, vaping, dabbing, ingestion, and tinctures, which further aid their market growth.

Browse in-depth TOC on “Cannabis Market”
132 – Tables
60 – Figures
224 – Pages

The medical segment is estimated to be the dominant segment in 2020.

The cannabis market, by application, is estimated to be dominated by the medical segment in 2020. Marijuana has been used as a medicine in different cultures for thousands of years. The use of cannabis is being legalized across countries for medical purposes for the treatment of various illnesses and ailments. Furthermore, the usage of medical CBD in the form of oils, topical pain relief treatment solutions, and edibles could also dissuade its smoke intake among patients while being equally effective medically. Medical cannabis remains the most effective mainly as it is also used for various health conditions, which include pain management, neurological health management, and mental health management.

The North American market is expected to hold the largest share in the cannabis market in 2020.

The North American cannabis market is primarily driven by growth in the US and Canadian markets. The market in this region is driven by the increasing legalization of cannabis for both medical and recreational purposes all over North America and increasing awareness among consumers regarding the health benefits of cannabis. The market is further driven by the presence of major cannabis giants such as Canopy Growth Corporation, Aurora Cannabis Inc., and Medical Marijuana Inc., who are continuously investing and collaborating for the development of new products to fulfill the demand of the consumers.

Furthermore, the legalization of recreational usage of cannabis in Canada in 2018 and 11 other states in the US for medical and recreational purposes is also expected to generate a huge opportunity for the cannabis market in the North American region. Other factors such as an increase in recognition of medical benefits of cannabis and growing consumer demand for cannabis in disease management and treatment due to high health care costs are expected to drive the growth in the North American region.

(This information is primarily sourced from MarketsandMarkets Research Pvt. Ltd.  Highly Capitalized has neither approved nor disapproved the contents of this news release. Read our Disclaimer here).

About the Author: News Team

Newsteam at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.

Share This Story, Choose Your Platform!

Latest News

  • Financial Result, CBD Skin Care Market, Cannabis Testing Market

Global Cannabis Testing Market Analysis Report 2023-2030

February 4th, 2023|

DUBLIN - Global Cannabis Testing Market to Reach $2.8 Billion by 2030 In the changed post COVID-19 business landscape, the global market for Cannabis Testing estimated at US$1.1 Billion in the year 2022, is projected to reach ...